Cargando…
Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial
INTRODUCTION: Vancomycin is frequently used in the treatment of late-onset sepsis in young infants and is routinely administered as intermittent infusions (IIV); however, existing IIV dosing guidelines achieve target vancomycin levels in less than half of infants. Continuous infusions of vancomycin...
Autores principales: | Gwee, Amanda, Cranswick, Noel, Donath, Susan M, Hunt, Rodney, Curtis, Nigel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231575/ https://www.ncbi.nlm.nih.gov/pubmed/30391914 http://dx.doi.org/10.1136/bmjopen-2018-022603 |
Ejemplares similares
-
Vancomycin is commonly under‐dosed in critically ill children and neonates
por: Sosnin, Natasha, et al.
Publicado: (2019) -
Vancomycin Spacer-induced Hemolysis
por: Sudhakaran, Anuraj, et al.
Publicado: (2019) -
Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial
por: Peel, Trisha, et al.
Publicado: (2019) -
Trends of Vancomycin-Resistant Enterococcus Infections in Cancer Patients
por: Rafey, Abdur, et al.
Publicado: (2022) -
Status of Biofilm Production and Vancomycin Resistance in Enterococcus in the Rural Population of Mathura, India
por: Kumar, Dinesh, et al.
Publicado: (2023)